MARKET

BDRX

BDRX

Biodexa Pharmaceuticals plc
NASDAQ
2.270
-0.030
-1.30%
After Hours: 2.210 -0.061 -2.67% 19:53 12/31 EST
OPEN
2.320
PREV CLOSE
2.300
HIGH
2.320
LOW
2.220
VOLUME
76.72K
TURNOVER
--
52 WEEK HIGH
92.00
52 WEEK LOW
2.220
MARKET CAP
1.41M
P/E (TTM)
-0.0032
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BDRX last week (1222-1226)?
Weekly Report · 12/29/2025 10:01
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 12/26/2025 12:05
Weekly Report: what happened at BDRX last week (1215-1219)?
Weekly Report · 12/22/2025 10:00
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 12/18/2025 17:06
Biodexa Pharmaceuticals Prices $10 Million U.S. Public Offering to Fund Pipeline
TipRanks · 12/18/2025 13:57
Biodexa Pharmaceuticals prices $10M best-efforts public offering; shares down
Seeking Alpha · 12/18/2025 13:43
Biodexa Pharmaceuticals Prices $10M Public Offering, Selling 157,000 ADS Units At $3.28 And 2.89M Pre-Funded Units
Benzinga · 12/18/2025 13:40
Biodexa Prices $10M Public Offering
Benzinga · 12/18/2025 13:38
More
About BDRX
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company. The Company is developing a pipeline of products for the treatment of diseases with unmet medical needs. The Company’s lead development program, eRapa, is under development for familial adenomatous polyposis and non-muscle invasive bladder cancer; tolimidone, under development as a for the treatment of type 1 diabetes; and MTX110, which is being studied in aggressive rare/orphan brain cancer indications, including recurrent glioblastoma, diffuse midline glioma, or DMG, and medulloblastoma. Its technologies include Q-Sphera, MidaCore and MidaSolve. The Q-Sphera platform is a polymer microsphere microtechnology used for sustained delivery to prolong and control the release of therapeutics over an extended period of time, from weeks to months. Its MidaSolve platform is an oligosaccharide nanotechnology that is used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors.

Webull offers Biodexa Pharmaceuticals PLC-ADR stock information, including NASDAQ: BDRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BDRX stock methods without spending real money on the virtual paper trading platform.